HCPCS Level II
Q5115
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
Codes near Q5115
These sit next to Q5115 in the CMS Level II file. All Q codes
- Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
- Q5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Q5112Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
- Q5113Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
- Q5114Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
- Q5116Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
- Q5117Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
- Q5118Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
- Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
- Q5120Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 63459-0103-10 | Truxima | Cephalon, LLC | 10 |
| 63459-0104-50 | Truxima | Cephalon, LLC | 50 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.